Camurus AB (publ) (0RD1.L) Stock Price
SEK711.5 2.9%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
8 -
Technical
8
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Camurus AB (publ), AI stock picks, stock alerts and much more.
0RD1.L AI Stock Analysis
Financial Performance
The company's revenue has shown a consistent positive trend, with an increase of 7.8% from the previous quarter and a year over year growth of 28%. This indicates that the company is expanding its business operations effectively. The gross profit also increased by 9% from the last quarter and by almost 32% YoY, reflecting efficient cost management. The operating income profit surged significantly by approximately 947.5%, indicating strong operational efficiency and profitability.
Stock Price
The stock price currently stands at SEK547.5, which is down by -7.4% in the last month. However, it is important to note that despite this recent dip, the stock's performance has been strong over a longer time frame as indicated by its above-average 200-day moving average of SEK384.14. The RSI value being below 50 suggests that the stock may be oversold at present.
Alternative Data Signals
In terms of alternative data signals, web traffic shows a slight decrease month over month but no significant changes are observed overall which could have substantial impact on Camurus AB (publ)'s stock performance in immediate future. There aren't any current job openings which might indicate either a halt in expansion or high employee retention rate.
Conclusion
In conclusion, despite recent downturns in share price and some negative indicators such as decreasing web traffic and lack of job openings, Camurus AB (publ) demonstrates solid financial performance with impressive revenue growth and profitability ratios suggesting potential for recovery and further growth making it somewhat bullish.
Note: This AI Stock Analysis is based on data as of December 07. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Camurus AB (publ) (0RD1.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Camurus AB (publ) (0RD1.L), currently trading at SEK711.5, will... Sign up to access price prediction.
About 0RD1.L
-
Camurus AB (publ), a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally.
-
Symbol
0RD1.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
42.1B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$394.5 0.3% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$142.1 0.9% |
6 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.23 1.5% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$6.64 2.1% |
5 |
 |
Esperion Therapeutics 0IIM.L |
$2.8 2.9% |
6 |
News
No news articles.
0RD1.L Alternative Data
Web Traffic
Camurus AB (publ) receives an estimated 13473 monthly visitors to camurus.com, which is down by -34% over the last month.
-
Web Traffic
13473
-
Change from Previous Month
34%
-
3 Month Change
31.1%
-
YoY Change
31.1%
LinkedIn Followers
10,439 are following Camurus AB (publ) on LinkedIn, up by 2.9% over the last month.
-
LinkedIn Followers
10439
-
Daily Change
1.3%
-
1 Month Change
2.9%
-
3 Month Change
10.6%
-
YoY Change
10.6%
Job Postings
Camurus AB (publ) currenly has an estimated 1 open job postings.
-
Job Postings
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Camurus AB (publ) has 265 employees, up by 1.5% over the last month.
-
LinkedIn Employees
265
-
Daily Change
0.8%
-
1 Month Change
1.5%
-
3 Month Change
3.9%
-
YoY Change
3.9%
Reddit Mentions
Camurus AB (publ) has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
Camurus AB (publ) was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0RD1.L Financials
0RD1.L Key Metrics
-
Total Revenue
SEK553.1M
-
Net Income
SEK147M
-
Earnings per Share
SEK2.5
-
Free cash flow
SEK83.4M
-
EBITDA
SEK190M
-
EBITDA Ratio
0.343575
-
Total Assets
SEK3.8B
0RD1.L 2-year Revenue & Income
0RD1.L 2-year Free Cash Flow
0RD1.L Technicals
0RD1.L SMA
0RD1.L RSI
FAQ
What's the current price of Camurus AB (publ) (0RD1.L) Stock?
The price of an Camurus AB (publ) (0RD1.L) share is SEK711.5.
What's the market cap of Camurus AB (publ)?
The current market cap of Camurus AB (publ) is 42.1B.
What are some stocks similar to Camurus AB (publ) (0RD1.L) that investors often compare it to?
Camurus AB (publ) (0RD1.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.
What is the forecast for Camurus AB (publ)'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Camurus AB (publ)'s stock price to be around SEK775.9 in 2026. Starting from the current price of SEK711.5, this represents a 9.1% change in price, indicating a bullish outlook for the stock.
How to buy Camurus AB (publ) (0RD1.L) Stock?
Camurus AB (publ) stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Camurus AB (publ) shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.